Table 6.

Follow-up data of group 1 in comparison with other studies

	Rick et al. [17]	Sayed et al. [18]	Alquasem et al. [14]	Present study
No.of patients	57	11	56	31
Median follow-up (months)	87	38.3	34	38
%asymptomatic	59%	63.3%	84%	83.8%
%relapse	40%	27%	16%	16%